DK3354280T3 - Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer - Google Patents

Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer Download PDF

Info

Publication number
DK3354280T3
DK3354280T3 DK18161288.8T DK18161288T DK3354280T3 DK 3354280 T3 DK3354280 T3 DK 3354280T3 DK 18161288 T DK18161288 T DK 18161288T DK 3354280 T3 DK3354280 T3 DK 3354280T3
Authority
DK
Denmark
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
DK18161288.8T
Other languages
English (en)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from EP11770625.9A external-priority patent/EP2624865B1/en
Application granted granted Critical
Publication of DK3354280T3 publication Critical patent/DK3354280T3/da

Links

DK18161288.8T 2010-10-06 2011-10-05 Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer DK3354280T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
EP11770625.9A EP2624865B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
DK3354280T3 true DK3354280T3 (da) 2020-09-28

Family

ID=45995014

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18161288.8T DK3354280T3 (da) 2010-10-06 2011-10-05 Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer
DK11770625.9T DK2624865T3 (da) 2010-10-06 2011-10-05 Stabiliserede formuleringer indeholdende anti-interleukin-4 receptor-(IL-4R) antistoffer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11770625.9T DK2624865T3 (da) 2010-10-06 2011-10-05 Stabiliserede formuleringer indeholdende anti-interleukin-4 receptor-(IL-4R) antistoffer

Country Status (13)

Country Link
AR (1) AR083338A1 (da)
DK (2) DK3354280T3 (da)
ES (2) ES2820246T3 (da)
HR (1) HRP20181822T1 (da)
HU (1) HUE052089T2 (da)
LT (1) LT2624865T (da)
PT (1) PT3354280T (da)
RS (1) RS57850B1 (da)
SI (1) SI2624865T1 (da)
SM (1) SMT201800488T1 (da)
TW (7) TWI679988B (da)
UA (1) UA111731C2 (da)
UY (1) UY33652A (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9574004B2 (en) 2012-08-21 2017-02-21 Sanofi Biotechnology Methods for treating or preventing asthma by administering an IL-4R antagonist
TWI707694B (zh) * 2013-06-21 2020-10-21 法商賽諾菲生物技術公司 Il-4r拮抗劑用於製造治療鼻息肉症的藥物之用途
CN111437387B (zh) * 2013-06-21 2024-10-01 赛诺菲生物技术公司 通过施用il-4r拮抗剂治疗鼻息肉症的方法
AU2015346150B2 (en) 2014-11-14 2021-08-19 Regeneron Pharmaceuticals, Inc. Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
CA3079946A1 (en) 2017-10-30 2019-05-09 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
BR112022000740A2 (pt) 2019-07-16 2022-07-05 Sanofi Biotechnology Métodos para tratamento ou prevenção de asma por administração de um antagonista de il-4r

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
KR101593726B1 (ko) * 2008-09-10 2016-02-18 니혼 엑스란 고교 (주) 가교 아크릴레이트계 섬유 및 이의 제조방법
AU2010221156A1 (en) * 2009-03-06 2011-09-22 Genentech, Inc. Antibody formulation

Also Published As

Publication number Publication date
HK1258305A1 (en) 2019-11-08
AR083338A1 (es) 2013-02-21
UY33652A (es) 2012-04-30
UA111731C2 (uk) 2016-06-10
LT2624865T (lt) 2018-10-25
HUE052089T2 (hu) 2021-04-28
TW201542229A (zh) 2015-11-16
TW201221141A (en) 2012-06-01
RS57850B1 (sr) 2018-12-31
TW202102262A (zh) 2021-01-16
SMT201800488T1 (it) 2018-11-09
TW202320851A (zh) 2023-06-01
DK2624865T3 (da) 2018-10-22
TWI718890B (zh) 2021-02-11
PT3354280T (pt) 2020-09-01
TWI568445B (zh) 2017-02-01
ES2687813T3 (es) 2018-10-29
TWI679988B (zh) 2019-12-21
TW202026011A (zh) 2020-07-16
TWI782325B (zh) 2022-11-01
TW201716086A (zh) 2017-05-16
ES2820246T3 (es) 2021-04-20
TWI498121B (zh) 2015-09-01
HRP20181822T1 (hr) 2018-12-28
TWI690329B (zh) 2020-04-11
TWI856388B (zh) 2024-09-21
SI2624865T1 (sl) 2018-10-30
TW201924718A (zh) 2019-07-01

Similar Documents

Publication Publication Date Title
IL283424B1 (en) Stabilized formulations that include antibodies against the interleukin receptor (il-4r)
IL265501B (en) Stabilized antibody-containing liquid formulations
DK3756652T3 (da) Stabiliserede formuleringer indeholdende anti-interleukin-6 receptor (IL-6R)-antistoffer
IL295275B2 (en) High concentration antibody formulations
EP2588141A4 (en) ANTIBODY FORMULATIONS
DK3354280T3 (da) Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer